Pharmacokinetics of an Increased Atazanavir Dose with and without Tenofovir During the Third Trimester of Pregnancy

BACKGROUND: Reduced atazanavir exposure has been demonstrated during pregnancy with standard atazanavir/ritonavir dosing. We studied an increased dose during the third trimester of pregnancy. METHODS: IMPAACT 1026s is a prospective, non-blinded pharmacokinetic study of HIV-infected pregnant women ta...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kreitchmann, Regis, Best, Brookie M., Wang, Jiajia, Stek, Alice, Caparelli, Edmund, Watts, D. Heather, Smith, Elizabeth, Shapiro, David E., Rossi, Steve, Burchett, Sandra K., Hawkins, Elizabeth, Byroads, Mark, Cressey, Tim R., Mirochnick, Mark
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3625451/
https://ncbi.nlm.nih.gov/pubmed/23392467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0b013e318289b4d2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars